INS and obesity disorder: In this complex process, apart from obesity-associated insulin resistance, other metabolic factors play a key role in the evolution of MetS, including inflammatory factors [60], defects in the target cell (i.e., receiver and post-receiver) [2], and an increase in insulin counterregulatory hormones and anti-insulin antibodies (AIA) [61].